Navigation Links
TorreyPines Therapeutics Licenses Intellectual Property from Johns Hopkins Related to Novel Uses of Glutamate Receptor Antagonists for Prevention, Treatment of Stroke, Heart Attack
Date:5/1/2008

ompany is currently developing four product candidates, two ionotropic glutamate receptor antagonists and two muscarinic receptor agonists. Further information is available at http://www.torreypinestherapeutics.com.

This press release contains forward-looking statements or predictions. Such forward-looking statements include, but are not limited to, statements regarding the potential for tezampanel and NGX426 as a treatment for stroke, heart attack and other conditions associated with increased platelet aggregation and the potential for tezampanel and NGX426 as treatments for migraine and other forms of chronic pain such as neuropathic pain, muscle spasticity and rigidity, thrombosis, epilepsy, Parkinson's disease and central sensitization. Such statements are subject to numerous known and unknown risks, uncertainties and other factors, which may cause TorreyPines' actual results to be materially different from historical results or from any results expressed or implied by such forward-looking statements, including whether any preclinical studies or clinical trials conducted in the future, will prove successful, and if successful, whether the results can be replicated. These and other risks which may cause results to differ are described in greater detail in the "Risk Factors" section of TorreyPines' annual report on Form 10-K for the year ended December 31, 2007 and TorreyPines other SEC reports. The forward-looking statements are based on current information that is likely to change and speak only as of the date hereof.

Company Contact: Media Contact:

Ev Graham David Schull

TorreyPines Therapeutics, Inc. Russo Partners, LLC

858-623-5665, x118 212-845-4271

egraham@torreypinestherapeutics.com

SOURCE TorreyPines Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Gamma Secretase Modulators Show Promise in Alzheimers Disease Animal Model Efficacy Studies, According to Research Conducted by TorreyPines Therapeutics
2. TorreyPines Therapeutics to Present at BMO Capital Markets Focus on Healthcare Conference
3. TorreyPines Therapeutics to Present at the JMP Securities Healthcare Focus Conference
4. Transition Therapeutics to Present at 2008 Morgan Stanley Global Healthcare Unplugged Conference
5. Duska Therapeutics Plans 505(b)(2) NDA Filing Route for ATPace(TM)
6. Echo Therapeutics and Cato BioVentures Sign Right of First Offer Agreement for Dermatology Products and Transdermal Drug Delivery Technologies
7. CV Therapeutics to Announce 2008 First Quarter Financial Results on Friday, April 25, 2008
8. Precision Therapeutics Adds 8 Million Covered Lives Under Contract
9. Hyperion Therapeutics Elects Lota Zoth to Board of Directors
10. Antisense therapeutics scientist out to pull more big deals
11. Vista Partners Initiates Coverage on Arana Therapeutics (ASX: AAH; AIM: AAHx)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008).... 21 A prestigious group of physic... gather in Williamsburg, VA on March 27-29, 2009 a...cal information on cutting-edge therapeutic protoc...esearch advances that impact patient care. The ful...n information is available at www.bioconferences....
(Date:11/21/2008)... use is more prevalent and smoking cessation less ...ctivity Disorder (A.D.H.D.) In a study of smokers..., those who exhibited elevated hyperactivity and i...wer quit rates after 8 weeks than those with inatt.... symptoms. The study, now available online in N...
(Date:11/21/2008)...RNewswire/ -- Three Minnesotans who successfully,...ial on-ice presentation at,the Minnesota Wild gam...nners,were participants in The QuitCash Challenge...ota(SM) and QUITPLAN(R) Services. , The gra... two runners-up,will get $1,000 gift cards from G...
(Date:11/21/2008)...RNewswire/ -- In a recent announcement, Governor,...d Use Tax to include,"luxury" items such as veter...,in animal shelter overpopulation. Animal welfar...nd urging all pet owners to take action and contac... tax. , "Our companion animals are family m...
Breaking Medicine News(10 mins):Health News:17th Annual Congress on Women's Health Convenes March 27-29, 2009 in Williamsburg, VA 2Health News:Ability to quit smoking may depend on ADHD symptoms, Columbia researchers find 2Health News:Lucky Quitters to Receive Big Money in Stop-Smoking Contest 2Health News:A Recommended Sales and Use Tax Proposed by Governor Schwarzenegger Will Tax Veterinary Services, Says Social Compassion in Legislation 2Health News:A Recommended Sales and Use Tax Proposed by Governor Schwarzenegger Will Tax Veterinary Services, Says Social Compassion in Legislation 3
...om Columbia University Medical Center have uncover...itch for severe pain. They hope to manufacture dru...imply switching off. // Most prior attempts at al... the "second order" neurons in the spinal cord tha...
...nd Social Welfare’s Health Education Unit (HEU) in...on program for more than 40 communities in the cou...e' attempts to get the people thinking abut HIV AI...rgency Response Council on HIV and AIDS (NERCHA) P...
...gators at St. Jude Children's Research Hospital it...the normal mammary gland function during nursing c...n leukemia only if it undergoes mutation and fuses... normal function of this gene suggests that drugs ...
...der who experience migraines with aura (associated...urbances) are at a higher risk for heart// attack,... cardiovascular disease compared to women who do n...ne without aura, the most common form of migraine,...
Other Medicine News:Health News:It may be possible to switch off acute pain 2Health News:Gene Responsible For Mammary Gland Function, When Mutated Results in Leukemias 2Health News:Gene Responsible For Mammary Gland Function, When Mutated Results in Leukemias 3Health News:Migraines with Aura Associated with Increased Risk for Cardiovascular Disease 2
(Date:11/19/2008)...m Roche- , , MONTVALE, N.J., Nov. 19 /PRNew...Nasdaq: MEMY ) today announced that it has achie...3487/MEM 3454, its lead alpha-7 nicotinic receptor...schizophrenia (CIAS). The Company has randomized ....0 million payment from its partner Roche. Memory...
(Date:11/18/2008)...ire-USNewswire/ -- Forty-two leading U. S. scienti...l forum to consider cutting-edge innovations that ...onomy from outbreaks of dangerous zoonotic disease...ng those innovations: , , , , A...at detects highly contagious and dangerous zoonoti...
(Date:11/13/2008)...al Supplements Prior to Surgery, ARLINGTON HEIGHT...fying,malnutrition before surgery in massive weigh...ficantly decrease surgical complications, accelera...atient energy levels,according to a study in the ...ry(R), the official medical journal of the America...
(Date:11/12/2008)...ael, November 12 Surgeons,at the U...d that,patient-specific CTA data can be converted ...mbionix US) with high face validity. The surgeons,... operative flow,increased patient safety and effi...ive and fluoroscopy time and the amount of contras...
Breaking Medicine Technology:Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 2Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 342 Top U.S. Scientists and Specialists Explore Cutting-Edge Innovations to Defend America From Dangerous Zoonotic Diseases 2Plastic Surgeons Warn of Malnutrition in Body Contouring Patients 2Vascular Surgeons Agree: Case Rehearsal Improves Outcomes 2Effective health messages may yield vaccine compliance among ER workers 22136 1Effective health messages may yield vaccine compliance among ER workers 22136 2Bill Allowing Medical Privacy Intrusion Fails in Sacramento 3B Anti Privacy Bill by Auto Insurers Faces Vote Wednesday 22133 1Bill Allowing Medical Privacy Intrusion Fails in Sacramento 3B Anti Privacy Bill by Auto Insurers Faces Vote Wednesday 22133 2Bill Allowing Medical Privacy Intrusion Fails in Sacramento 3B Anti Privacy Bill by Auto Insurers Faces Vote Wednesday 22133 3AMA Adopts New Policies at Annual Meeting 22128 1AMA Adopts New Policies at Annual Meeting 22128 2Hospital Workers Say Concessions Will Diminish Patient Care 22125 1Hospital Workers Say Concessions Will Diminish Patient Care 22125 2
...)--Mar 15, 2007 - A small clinical,trial of a medi...,conclusive benefit for patients with the impulsiv...he Stanford University,School of Medicine., But th...ications, including the one in the trial, may stil..., More than 1.2 million people in the United State...
...ewswire/ -- Up to two million,Americans are affect...ed. Its primary complication, pulmonary embolism (...han breast cancer and,AIDS combined. , The Coaliti...sponsored an online survey of a nationally represe...rvey, which was conducted by Penn,Schoen & Be...
Other Medicine Technology:Stanford Study Finds No Conclusive Benefit From Treating,Kleptomania With Medication 2DVT Awareness Survey Findings for Respondents in High-Risk Groups:,Obese Individuals 2
...veloped for the World Health Organization as a non... widely used in clinical trials and in the assessm...les are diluted in buffer and the Estrone-3-Glucur...ed immunoassay with magnetic second antibody separ...
The DSL 10-8700 ACTIVE® Estrone Enzyme Immunosorbent Assay (EIA) Kit provides materials for the quantitative measurement of Estrone in serum. The procedure follows the basic principle of enzyme i
Helmer presents the i.Series refrigerator iB245, packed with innovative solutions for the blood bank. With more sophisticated features than ever before, i.Series Blood Bank Refrigerators are at the f
This storage freezer, which is based on our premium freezer line, maintain red cells safely below regulatory standards at -86C (-123F). Recorder is standard for model 8627. Model 8627 is UL Listed, C
Medicine Products: